Clinical Trials Scorecard for Clinical Trial Investigations in 2022
Summary
This report provides an overview of global clinical trials with a start date between January 1, 2022, and December 31, 2022.
Scope
- The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data included clinical trials with a start date between January 1, 2022 and December 31, 2022, which were captured in the database as of February 14, 2023. The trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, molecule type, and top drug trials.
- Trends of 2022 trial landscape
- Comparison to 2021 trial landscape
- Can view top therapy areas,indications, geographies and sponsors for 2022 trials
- Designated focus on completed and terminated trials for 2022
- Spotlight on COVID-19
- Executive Summary
- Introduction
- Global Clinical Trial Landscape in 2022
- Completed Trials in 2022
- Clinical Trial Terminations in 2022
- Spotlight on COVID-19 Clinical Trials for 2022
- Key Findings
- Appendix
- List of Figures
- Figures 1 and 2: Clinical trials by sponsor type, status and initiation/completion
- Figures 3 and 4: Clinical trials, by phase and sponsor type
- Figure 5: Single country and multinational trials
- Figure 6: Clinical trials regions, by phase
- Figure 7: Clinical trials regions, by phase and distribution
- Figure 8: Clinical trials in top countries, by phase
- Figure 9: Clinical trials in top countries, by phase and distribution
- Figure 10: Clinical trials top therapy areas, by phase
- Figure 11: Clinical trials top therapy areas, by phase and distribution
- Figure 12: Pivotal/registration clinical trials top therapy areas, by phase
- Figure 13: Clinical trials top indications, by phase
- Figure 14: Clinical trials top indications, by phase and distribution
- Figure 15: Pivotal/registration clinical trials top indications, by phase
- Figure 16: Clinical trials top industry sponsors, by phase
- Figure 17: Clinical trials top non-industry sponsors, by phase
- Figure 18: Pivotal/registration clinical trials top industry sponsors, by phase
- Figure 19: Completed trials endpoint status, by sponsor type
- Figures 20 and 21: Completed trials endpoint status, by sponsor type and phase
- Figure 22: Pivotal/registration industry-sponsored trials endpoint status, by phase
- Figure 23: Completed clinical trials top sponsors, by phase
- Figure 24: Top completed drugs, by clinical trial count
- Figures 25 and 26: Terminated trials, by phase and reason
- Figure 27: Terminated clinical trials top therapy areas, by phase
- Figure 28: Terminated clinical trials top indications, by phase
- Figure 29: Terminated clinical trials for sponsors, by phase
- Figure 30: Clinical trials for COVID-19, by status and sponsor type
- Figure 31: Clinical trials for COVID-19, by phase
- Figure 32: Clinical trials for COVID-19, by top industry sponsors
- Figure 33: Clinical trials for COVID-19, by top non-industry sponsors
- Figures 34 and 35: Clinical trials for COVID-19, by molecule type and phase
- Figures 36 and 37: Virtual trial components
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook